Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Whitley

Showing results (351-360 of 489) with videos related to

Pageof 49
Sort By:
Gene Therapy|April 16, 1998
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukinsS Andreansky, B He, J van Cott, et al.
Pediatrics|September 1, 1981
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective studyS Stagno, D M Brasfield, M B Brown, et al.
Cancer Gene Therapy|September 23, 2006
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumorsM B Guffey, J N Parker, W S Luckett, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivoVassiliki Kostourou, Helen Troy, Joanne F Murray, et al.
Cancer Research|April 15, 1997
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumorsS Andreansky, L Soroceanu, E R Flotte, et al.
Pediatrics|December 1, 1983
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapyR J Whitley, A Yeager, P Kartus, et al.
Human Reproduction (Oxford, England)|May 20, 2008
Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinasesHeather L LaMarca, Philip R Dash, Keshika Vishnuthevan, et al.
Vaccine|October 26, 2005
Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidatesJacqueline N Parker, Luz-Andrea Pfister, Debra Quenelle, et al.
The Journal of Infectious Diseases|June 20, 1998
Retraction: A rabbit model for human cytomeglovirus--induced chorioretinal disease (J Infect Dis 1993;168:336-44)E C Dunkel, D I Scheer, Q Zhu, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1987
Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteersB G Petty, R J Whitley, S Liao, et al.
Pageof 49

Showing results (351-360 of 489) with videos related to

Sort By:
Pageof 49
Gene Therapy|April 16, 1998
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukinsS Andreansky, B He, J van Cott, et al.
Pediatrics|September 1, 1981
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective studyS Stagno, D M Brasfield, M B Brown, et al.
Cancer Gene Therapy|September 23, 2006
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumorsM B Guffey, J N Parker, W S Luckett, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivoVassiliki Kostourou, Helen Troy, Joanne F Murray, et al.
Cancer Research|April 15, 1997
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumorsS Andreansky, L Soroceanu, E R Flotte, et al.
Pediatrics|December 1, 1983
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapyR J Whitley, A Yeager, P Kartus, et al.
Human Reproduction (Oxford, England)|May 20, 2008
Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinasesHeather L LaMarca, Philip R Dash, Keshika Vishnuthevan, et al.
Vaccine|October 26, 2005
Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidatesJacqueline N Parker, Luz-Andrea Pfister, Debra Quenelle, et al.
The Journal of Infectious Diseases|June 20, 1998
Retraction: A rabbit model for human cytomeglovirus--induced chorioretinal disease (J Infect Dis 1993;168:336-44)E C Dunkel, D I Scheer, Q Zhu, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1987
Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteersB G Petty, R J Whitley, S Liao, et al.
Pageof 49